PP_1170x120_10-25-21

The Healthcare Distribution Alliance (HDA)

HDA pilot results in automation of authorized trading partner credentialing for DSCSA

HDA pilot results in automation of authorized trading partner credentialing for DSCSA

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA), in coordination with the Center for Supply Chain Studies, announced the successful conclusion of an industry-wide pilot of an interoperable ‘authorized trading partner’ credentialing ecosystem to support the requirements of the federal traceability law, the Drug Supply Chain Security Act (DSCSA). Pilot participants, other industry members and

HDA releases policy principles for COVID-19 vaccine distribution

HDA releases policy principles for COVID-19 vaccine distribution

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration. HDA highlights four priority areas for vaccine distribution:

HDA celebrates manufacturers with 2020 DIANA awards

HDA celebrates manufacturers with 2020 DIANA awards

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) honored five pharmaceutical and consumer product manufacturers with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA). Awardees were recognized in the “Best New Product Introductions or Promotions” categories. Annually presented at the Business and Leadership Conference (BLC), the awards were given virtually during the 2020 BLC Online.

HDA issues statement on HHS-FDA “Safe Importation Action Plan”

HDA issues statement on HHS-FDA  “Safe Importation Action Plan”

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement on the release of the “Safe Importation Action Plan” by the Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA): “Americans are rightly concerned about the rising costs of medicines. But as solutions are proposed to address the issue

Adheris Health